Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry.
Nasser M AlorfiMansour M AlourfiGhfran Abdulrahman BokhariAbdullah AlkhattabiNihal Abdallah IbrahimAbdulmalik Mohammed AlsabbanMohammad J AlmatrafiYaser Abdulaziz ZakriAbdullah Jasem AlmahmoudKhalid Mohammed A Al-GhamdiSaeed Nasser AlsharifPublished in: International journal of general medicine (2023)
Ustekinumab appears to be a promising treatment option for patients with IBD, with the potential to provide significant clinical benefits and a favourable safety profile. Further research is warranted to confirm these findings and explore optimal dosing and treatment regimens.